Medical Costs and Hospitalizations Among Patients with Depression Treated with Adjunctive Atypical Antipsychotic Therapy: An Analysis of Health Insurance Claims Data

Rachel Halpern, Anagha Nadkarni, Iftekhar Kalsekar, Hiep Nguyen, Rui Song, Ross A. Baker, J. Craig NelsonAnnals 2013 · DOI

Abstract

Compared with adjunctive olanzapine or quetiapine, adjunctive aripiprazole was associated with lower mean total and mental health-related medical costs and with lower odds of total and mental health-related hospitalizations in patients with depression.
BibTeX
@article{halpern2013medical,
  author = {Rachel Halpern and Anagha Nadkarni and Iftekhar Kalsekar and Hiep Nguyen and Rui Song and Ross A. Baker and J. Craig Nelson},
  title = {{Medical Costs and Hospitalizations Among Patients with Depression Treated with Adjunctive Atypical Antipsychotic Therapy: An Analysis of Health Insurance Claims Data}},
  journal = {Annals},
  year = {2013},
  doi = {10.1345/aph.1r622},
}

Loading related content...

Figure